Influence of a Medicinal Cannabinoid Agonist on Responses to Food Images and Food Intake

Status: Currently recruiting

Phase not specified

Belgium

Last date verified: 2014

https://clinicaltrials.gov/ct2/show/NCT02310347

Cannabics Capsules as Treatment to Improve Cancer Related CACS in Advanced Cancer Patients

Status: Currently recruiting

Phase III

Israel

Last date verified: 2016

https://clinicaltrials.gov/ct2/show/NCT02359123

Safety and Efficacy of Nabilone in Alzheimer’s Disease

Status: Currently recruiting

Phase II, Phase III

Canada

Last date verified: 2015

https://clinicaltrials.gov/ct2/show/NCT02351882

Trial of Dronabinol Adjunctive Treatment of Agitation in Alzheimer’s Disease (AD) (THC-AD) (THC-AD)

Status: Not yet recruiting

Phase II

United States

Last date verified: 2016

https://clinicaltrials.gov/ct2/show/NCT02792257

Sublingual Cannabidiol for Anxiety

Status: Not yet recruiting

Phase II

United States

Last date verified: 2015

https://clinicaltrials.gov/ct2/show/NCT02548559

Experimental Medicine in ADHD – Cannabinoids (EMA-C)

Status: Currently recruiting

Phase not specified

United Kingdom

Last date verified: 2014

https://www.clinicaltrials.gov/ct2/show/NCT02249299

A Study: Pure CBD as Single-agent for Solid Tumor

Status: Not yet recruiting

Phase II

Israel

Last date verified: 2014

https://clinicaltrials.gov/ct2/show/NCT02255292

A Study of Dexanabinol in Combination With Chemotherapy in Patients With Advanced Tumours

Status: ongoing

Phase I

Europe (Germany, Poland, Spain, United Kingdom)

Last date verified: 2016

https://clinicaltrials.gov/ct2/show/NCT02423239

A Study of GWP42004 as Add on to Metformin in the Treatment of Participants With Type 2 Diabetes

Status: currently recruiting

Phase II

United Kingdom, Romania

Last date verified: 2015

https://clinicaltrials.gov/ct2/show/NCT02053272

Cannabidiol (CBD) and Pediatric Epilepsy

Status: currently recruiting

Phase unspecified

United States

Last date verified: 2016

https://clinicaltrials.gov/ct2/show/NCT02447198

Cannabidiol (CBD) to 25 Patients (Aged 2 Years – 19 Years) With Drug Resistant Epilepsy

Status: ongoing

Phase I

United States

Last date verified: 2016

http://clinicaltrials.gov/show/NCT02286986

An Open Label Extension Study of Cannabidiol (GWP42003-P) in Children and Young Adults With Dravet or Lennox-Gastaut Syndromes

Status: enrolling participants by invitation

Phase III

Location unspecified

Last date verified: 2016

https://clinicaltrials.gov/ct2/show/NCT02224573

A Study to Investigate the Efficacy and Safety of Cannabidiol (GWP42003-P) in Children and Young Adults With Dravet Syndrome

Status: currently recruiting

Phase III

United States, Netherlands

Last date verified: 2016

https://clinicaltrials.gov/show/NCT02224703

A Study to Investigate the Efficacy and Safety of Cannabidiol (GWP42003-P; CBD) as Adjunctive Treatment for Seizures Associated With Lennox-Gastaut Syndrome in Children and Adults

Status: ongoing

Phase III

United States

Last date verified: 2015

https://clinicaltrials.gov/show/NCT02224560

Cannabidiol Expanded Access Study in Medically Refractory Sturge-Weber Syndrome

Status: ongoing

Phase I, Phase II

United States

Last date verified: 2016

http://clinicaltrials.gov/show/NCT02332655

The Use of Medicinal Cannabinoids as Adjunctive Treatment for Medically Refractory Epilepsy

Status: currently recruiting

Phase not specified

United States

Last date verified: 2016

https://clinicaltrials.gov/ct2/show/NCT02523183

Epidiolex and Drug Resistant Epilepsy in Children (CBD)

Status: expanded access

Phase not specified

United States

Last date verified: 2015

https://clinicaltrials.gov/ct2/show/NCT02397863

Effects of Marihuana Use on Optic Nerve Parameters and Ocular Blood Flow

Status: currently recruiting

Phase unspecified

Israel

Last date verified: 2015

https://clinicaltrials.gov/ct2/show/NCT02080676

Graft-Versus-Host disease

Cannabidiol for the Treatment of Severe (Grades III/IV) Acute Graft-versus-host Disease

Status: not yet recruiting

Phase II

Israel

Last date verified: 2015

https://clinicaltrials.gov/ct2/show/NCT02392780

Extended Use of Cannabidiol for the Prevention of Graft-versus-host-disease

Status: not yet recruiting

Phase II

Israel

Last date verified: 2015

https://clinicaltrials.gov/ct2/show/NCT02478424

The Effects of Cannabis on Dystonia and Spasticity on Pediatric Patients

Status: currently recruiting

Phase II

Israel

Last date verified: 2015

https://clinicaltrials.gov/show/NCT02470325

Phase 3, 28-week, Randomized, Double-blind, Placebo-controlled Safety and Efficacy Study of Nabiximols as an add-on Therapy in Subjects With Spasticity Due to Multiple Sclerosis

Status: not yet recruiting

Phase III

Not specified

Last date verified: 2016

https://clinicaltrials.gov/ct2/show/NCT01868048

Cannabinoid Profile Investigation of Vapourized Cannabis in Patients With Osteoarthritis of the Knee (CAPRI)

Status: currently recruiting

Phase II

Canada

Last date verified: 2016

http://clinicaltrials.gov/show/NCT02324777

The Safety, Tolerability and Efficacy of Dronabinol, for the Treatment of Nausea and Vomiting in Familial Dysautonomia

Status: currently recruiting

Phase II

United States

Last date verified: 2016

http://clinicaltrials.gov/show/NCT02608931